J9218 Leuprolide acetate injeciton
Also known as: leuprolide, Lupron
Intravenous injection of leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist.
In Plain Language
testosterone-lowering prostate cancer treatment; hormone therapy
Clinical Context
Used for advanced prostate cancer and uterine fibroids as hormone suppressive therapy.
RVU Information
CPT J9218 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9218?
CPT J9218 (Leuprolide acetate injeciton) is a J Codes (Drugs) code. Intravenous injection of leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist.
How is J9218 administered?
CPT J9218 is administered by a healthcare provider, typically via injection or infusion. Used for advanced prostate cancer and uterine fibroids as hormone suppressive therapy. It is used by Urology, Oncology.
When is CPT J9218 used?
Used for advanced prostate cancer and uterine fibroids as hormone suppressive therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.